ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Infectious Diseases
Volume 13 - 2025 | doi: 10.3389/fped.2025.1573933
Comparison of COVID-19-Associated Inpatient Burden by Variant Period in Hospitalized Children Age <5 Years in the United States
Provisionally accepted- Pfizer, New York, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: This study evaluated clinical outcomes in children aged <5 years with COVID-19-associated hospitalizations and assessed whether disease severity differed across periods of SARS-CoV-2 variant predominance in the United States. Methods: Data from the PINC AI™ Healthcare Database during three distinct periods of SARS-CoV-2 variant predominance (pre-Delta [April 2021-June 2021], Delta [July 2021-December 2021], and Omicron [January 2022-July 2023]) were used. Hospital length of stay (LOS), admission to the intensive care unit (ICU), ICU LOS, usage and duration of oxygen supplementation, usage and duration of invasive mechanical ventilation (IMV), and inpatient death were assessed for each period.Results: Overall, 10,316 children aged <5 years were hospitalized for COVID-19 over the three periods. Most pediatric COVID19 hospitalization occurred during the Omicron period. In each time period, children aged <1 year were disproportionately affected. For each outcome of interest, there were no statistically significant differences between variant periods. Similar proportions of hospitalized children required oxygen supplementation (pre-Delta 13%; Delta 16%; Omicron 18%), required IMV (pre-Delta 7%; Delta 8%; Omicron 7%) and experienced inhospital death (pre-Delta 0.7%; Delta 0.9%; Omicron 0.4%). Duration of hospital LOS, ICU LOS and IMV use were also similar.Conclusions: Despite perception that the omicron variant is less severe, children aged < 5 years have a similar risk of severe COVID-19 as they did in earlier variant eras. These results highlight the need for continued preventative measures against severe COVID-19 in children, including routine immunization for eligible children and pregnant people with an updated COVID-19 vaccine.
Keywords: COVID 19, SARS-COV-2 variants, Invasive mechanical ventilation, Intensive Care Unit, Pediatrics
Received: 10 Feb 2025; Accepted: 29 Apr 2025.
Copyright: © 2025 Andersen, Mccolgan, Cane, Moran, Reimbaeva and Lopez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Santiago Lopez, Pfizer, New York, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.